The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
CCOA Therapeutics Inc
5 records totalling $290,064.00 CAD, from official Government of Canada open data.
Embed this chart
By department
| National Research Council Canada | $290,064 | 5 records |
Records
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.
The project is to develop global regulatory strategy for therapeutics, in vitro diagnostics, natural health products, and laboratory research reagents of CCOA Therapeutics (CCOA). This strategy will a...
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
This project is to develop community-based prophylaxis for COVID-19 via our newly developed Angiotensin-Converting Enzyme 2 (ACE2) mimetics, and to develop marketing strategy for our innovative produc...